KOJIC DIPALMITATE

📋 Quick facts

Description: KOJIC DIPALMITATE — brightening, more stable and less irritating derivative of kojic acid.

All Functions: brightening, more stable and less irritating derivative of kojic acid

Quick Facts:

• Category: active

Proven Benefits At A Glance:

• Kojic dipalmitate (KDP) is an esterified form of kojic acid used in skin-whitening cosmetic products
• Research shows KDP has antioxidant properties and can inhibit tyrosinase, an enzyme involved in pigmentation
• In laboratory studies, KDP formulations showed no cytotoxicity at tested concentrations
• KDP is being studied in advanced delivery systems (nanoemulsions and multiple emulsions) to improve skin penetration
• The ingredient is relatively novel and still being studied for safety and efficacy in real-world use

📊 Comedogenicity

🛡️ Safety rating

Safety tier is a starting heuristic from regulatory status and comedogenic rating, not a dermatological verdict — see our Terms for the full disclaimer. Research confidence reflects how many real cited studies back this ingredient, not the strength of their findings.

🌍 Regulatory Status

💧 Skin Type Compatibility

⚠️ Don’t Combine With

📚 Research & Evidence

🔬 The Science

Kojic dipalmitate is the esterified derivative of kojic acid, designed to improve how the ingredient penetrates skin. Here’s what the research currently shows: #1: In vitro studies demonstrate that KDP has tyrosinase inhibitory activity—meaning it can reduce the enzyme responsible for melanin production—with antioxidant and depigmenting efficacy comparable to ascorbic acid (vitamin C) in laboratory tests (Pharmaceutics, 2023). #2: Researchers have developed nanoemulsion and multiple emulsion delivery systems to carry KDP into skin more effectively, as these carrier systems are described as “lipophilic antioxidants” that can increase bioavailability and maintain antioxidant activity better than KDP alone (Biomed Res Int, 2015; Pharmaceutics, 2023).

#3: In cell culture studies, KDP showed no cytotoxicity at concentrations ranging from 0.06% to 1% (Pharmaceutics, 2023), and multiple emulsion formulations containing KDP “improved the safety profile” compared to unloaded systems (Biomed Res Int, 2015). #4: One clinical case report documented a patient who developed depigmented patches after using a skin-lightening cream containing KDP, though this represents a single observation rather than systematic safety data (Clin Exp Dermatol, 2010). The sources are primarily focused on laboratory development and in vitro testing; robust clinical efficacy and safety data in larger populations appear limited.

📄 Related Research

Matched by search — not necessarily verified support for every statement above.

• Balaguer A et al. (2008). A rapid and reliable size-exclusion chromatographic method for determination of kojic dipalmitate in skin-whitening cosmetic products. Talanta.
• Zilles JC et al. (2023). Nanoemulsion Containing Kojic Dipalmitate and Rosehip Oil: A Promising Formulation to Treat Melasma. Pharmaceutics.
• Gonçalez ML et al. (2015). Structural characterization and in vitro antioxidant activity of kojic dipalmitate loaded w/o/w multiple emulsions intended for skin disorders. Biomed Res Int.
• Madhogaria S et al. (2010). Leucoderma after use of a skin-lightening cream containing kojic dipalmitate, liquorice root extract and Mitracarpus scaber extract. Clin Exp Dermatol.

🧴 Products Containing KOJIC DIPALMITATE